These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6786297)

  • 1. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase.
    Cory JG; Lasater L; Sato A
    Biochem Pharmacol; 1981 May; 30(9):979-84. PubMed ID: 6786297
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
    Cory JG; Sato A; Lasater L
    Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
    Sato A; Bacon PE; Cory JG
    Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
    Sato A; Cory JG
    Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
    Moore EC; Hurlbert RB
    Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of the active site of ribonucleotide reductase of Escherichia coli, bacteriophage T4 and mammalian cells by inhibition studies with hydroxyurea analogues.
    Larsen IK; Sjöberg BM; Thelander L
    Eur J Biochem; 1982 Jun; 125(1):75-81. PubMed ID: 7049700
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of ribonucleotide reductases encoded by herpes simplex viruses.
    Spector T
    Pharmacol Ther; 1985; 31(3):295-302. PubMed ID: 3035588
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uridine diphosphate reductase of Ehrlich ascites tumor is insensitive to hydroxyurea.
    Murayama J; Morita T; Fukui N; Moriyama Y; Fujimura S
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1104-8. PubMed ID: 3884001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins.
    Hodges YK; Antholine WE; Horwitz LD
    Biochem Biophys Res Commun; 2004 Mar; 315(3):595-8. PubMed ID: 14975742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure.
    Tipples G; McClarty G
    J Bacteriol; 1991 Aug; 173(16):4932-40. PubMed ID: 1860812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
    Lewis WH; Wright JA
    J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quenching of tyrosine radicals of M2 subunit from ribonucleotide reductase in tumor cells by different antitumor agents: an EPR study.
    Liermann B; Lassmann G; Langen P
    Free Radic Biol Med; 1990; 9(1):1-4. PubMed ID: 2170241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of P388 murine leukemia cells to hydroxyurea cytotoxicity by hydrophobic iron-chelating agents.
    Satyamoorthy K; Chitnis M; Basrur V
    Anticancer Res; 1986; 6(2):329-33. PubMed ID: 3518597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
    Cory JG; Mansell MM
    Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
    McClarty GA; Chan AK; Wright JA
    Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of mammalian ribonucleotide reductase activity in intact permeabilized cells: a genetic approach.
    Wright JA; Hards RG; Dick JE
    Adv Enzyme Regul; 1980; 19():105-27. PubMed ID: 7039254
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor.
    Nocentini G; Barzi A
    Gen Pharmacol; 1997 Nov; 29(5):701-6. PubMed ID: 9347313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
    Spector T; Jones TE
    J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of chelating agents on the distribution and excretion of radioiron in rats].
    Günther R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(4):405-18. PubMed ID: 4238109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.